Diamines & Chemicals Limited Converts Warrants into Equity Shares
Diamines & Chemicals Limited announced the conversion of 2,69,402 warrants into an equal number of equity shares on March 24, 2026. The conversion resulted in the allotment of 2,69,402 equity shares with a face value of Rs. 10 each.The company received Rs. 11,15,32,428, equivalent to Rs. 414 per warrant, representing 75% of the issue price, from warrant holders for the conversion.
The following table details the warrant conversion by allottee category:
| Sr. No. | Name of the Allottees | Category | No. Warrants Held | Amount Received (in Rs.) | No. of Equity Shares Allotted | No. of warrants pending for conversion |
|---|---|---|---|---|---|---|
| 1. | Amit Mahendrakumar Mehta | Promoter | 1,42,920 | 2,95,84,440 | 71,460 | 71,460 |
| 2. | Cherry A Mehta | Promoter | 1,35,164 | 2,79,78,948 | 67,582 | 67,582 |
| 3. | Mohak Amit Mehta | Promoter | 81,092 | 1,67,86,044 | 40,546 | 40,546 |
| 4. | Harsh Amit Mehta | Promoter | 73,632 | 1,52,41,824 | 36,816 | 36,816 |
| 5. | S Amit Speciality Chemicals Private Limited | Promoter | 36,500 | 75,55,500 | 18,250 | 18,250 |
| 6. | Perfo Chem India Private Limited | Promoter | 32,391 | 67,05,144 | 16,196 | 16,195 |
| 7. | Finorga (India) Private Limited | Promoter | 25,503 | 52,79,328 | 12,752 | 12,751 |
| 8. | Godiawala Tanmay Naimish | Non-Promoter | 12,300 | 24,01,200 | 5,800 | 6,500 |
| Total | Total | Total | 5,39,502 | 11,15,32,428 | 2,69,402 | 2,70,100 |
Following the conversion, 6,36,988 warrants remain pending for conversion. These warrants can be converted into equity shares within 18 months from the date of allotment, requiring the payment of the remaining 75% of the warrant amount. If this amount is not paid by the due date, the warrant subscription money already paid will be forfeited and the warrants will be cancelled.
The company’s Issued, Subscribed, and Paid-up Equity Share Capital has increased from Rs. 9,78,39,900 comprising 97,83,990 shares to Rs. 10,05,33,920 comprising 1,00,53,392 shares. The newly allotted shares will rank pari passu with existing equity shares, subject to necessary corporate actions and approvals.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.